As with all chronic diseases, it would be much more profitable to prevent obesity than to cure it by attacking the causes of this overweight as a priority, rather than devoting all our efforts and financial means to their treatment
Cost considerations for peptide therapy Rogan's wealth means cost isn't a limiting factor for his health optimization
Chanmee T, Ontong P, Itano N
DVT can lead to severe complications, including pulmonary embolisms (PEs)
This chronic immune stimulation contributes to systemic inflammation, immune exhaustion, and the ebbing-and-flowing symptom pattern many long COVID patients describe, where they feel marginally better and then crash again
The arrival of oral GLP-1 therapies marks the beginning of a new chapter in obesity pharmacotherapy.